Daily Stock Analysis, ICCC, ImmuCell Corp, priceseries

ImmuCell Corp. Daily Stock Analysis
Stock Information
Open
5.75
Close
5.35
High
5.90
Low
5.35
Previous Close
5.25
Daily Price Gain
0.10
YTD High
8.28
YTD High Date
Feb 14, 2019
YTD Low
5.15
YTD Low Date
Sep 6, 2019
YTD Price Change
-1.69
YTD Gain
-24.01%
52 Week High
9.30
52 Week High Date
Oct 9, 2018
52 Week Low
5.15
52 Week Low Date
Sep 6, 2019
52 Week Price Change
-3.10
52 Week Gain
-36.69%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 27. 2017
6.44
Oct 30. 2017
7.66
23 Trading Days
18.88%
Link
LONG
May 2. 2018
7.34
May 14. 2018
7.86
8 Trading Days
7.02%
Link
LONG
Sep 5. 2018
6.97
Sep 18. 2018
7.80
9 Trading Days
11.91%
Link
Company Information
Stock Symbol
ICCC
Exchange
NasdaqCM
Company URL
http://www.immucell.com
Company Phone
2078782770
CEO
Michael F. Brigham
Headquarters
Maine
Business Address
56 EVERGREEN DR, PORTLAND, ME 04103
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000811641
About

ImmuCell Corp. operates as a biotechnology company, which engages in the development, manufacture, and sale of products to improve animal health and productivity in the dairy and beef industry. Its products focus on prevention, diagnosis, and treatment of bovine diseases. The company was founded by Frank E. Ruch in 1982 and is headquartered in Portland, ME.

Description

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity in the dairy and beef industries in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product that provides bovine antibodies for newborn calves; Wipe Out Dairy Wipes, which consist of towelettes that are pre-moistened with a Nisin-based formulation to prepare the teat area of a cow in advance of milking; and California Mastitis Test that could be used for bulk tank and individual cow sample monitoring, as well as to determine which quarter of the udder is mastitic. It is also involved in the development of Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows; and treatments that prevent E. coli K99 and bovine coronavirus, as well as calf scours caused by enteric pathogens. In addition, the company sells various product applications of its First Defense Technology, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products to distributors and bovine veterinarians, as well as directly to producers. The company was founded in 1982 and is based in Portland, Maine.